Rhythm’s Setmelanotide Loses Fast-Track Status In Europe

Product Reverts To Standard Review; US Approval Decision Due This Month

Background concept wordcloud illustration of obesity fat overweight
Many patients with severe obesity experience debilitating comorbidities • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography